Optimizing pain control through the use of implantable pumps

Wilfried Ilias1, Boris Todoroff21Dept Anesthesiology, Intensive Care Medicine and Pain Therapy, Academic Teaching Hospital St. John of God, Vienna, Austria; 2Dept. Plastic and Reconstructive Surgery, Hospital of St. Vincent, Vienna, AustriaAbstract: Intrathecal therapy represents an effective and we...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Boris Todoroff, Wilfried Ilias
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://doaj.org/article/16e8761409ee41a3bfb4c4c7f4f53f95
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:16e8761409ee41a3bfb4c4c7f4f53f95
record_format dspace
spelling oai:doaj.org-article:16e8761409ee41a3bfb4c4c7f4f53f952021-12-02T00:55:53ZOptimizing pain control through the use of implantable pumps1179-1470https://doaj.org/article/16e8761409ee41a3bfb4c4c7f4f53f952008-10-01T00:00:00Zhttp://www.dovepress.com/optimizing-pain-control-through-the-use-of-implantable-pumps-a2495https://doaj.org/toc/1179-1470Wilfried Ilias1, Boris Todoroff21Dept Anesthesiology, Intensive Care Medicine and Pain Therapy, Academic Teaching Hospital St. John of God, Vienna, Austria; 2Dept. Plastic and Reconstructive Surgery, Hospital of St. Vincent, Vienna, AustriaAbstract: Intrathecal therapy represents an effective and well established treatment of nonmalignant as well as malignant pain. Devices available include mechanical constant flow pumps as well as electronic variable flow pumps with patient-controlled bolus release. The latter provide faster dose finding, individual pain control, and good acceptance by patients. New technologies such as membrane pumps and rechargeable devices are expected to be developed to clinical perfection. The available drugs for intrathecal therapy are listed according to the polyanalgesic consensus on intrathecal therapy. The integration of remote patient-controlled analgesia into electronic implantable devices, and the peptide analgesic ziconotide, have significantly improved intrathecal therapy. Complications include infections, catheter ruptures or disconnections, catheter granulomas, and technical dysfunctions. Further possibilities for optimizing intrathecal therapy include development of new drugs, drug side effects, catheter and pump technologies, and surgical techniques.Keywords: intrathecal therapy, implantable pumps, morphine pumps, intrathecal drugs, intrathecal catheters, intrathecal pain control Boris TodoroffWilfried IliasDove Medical PressarticleMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol 2008, Iss default, Pp 41-47 (2008)
institution DOAJ
collection DOAJ
language EN
topic Medical technology
R855-855.5
spellingShingle Medical technology
R855-855.5
Boris Todoroff
Wilfried Ilias
Optimizing pain control through the use of implantable pumps
description Wilfried Ilias1, Boris Todoroff21Dept Anesthesiology, Intensive Care Medicine and Pain Therapy, Academic Teaching Hospital St. John of God, Vienna, Austria; 2Dept. Plastic and Reconstructive Surgery, Hospital of St. Vincent, Vienna, AustriaAbstract: Intrathecal therapy represents an effective and well established treatment of nonmalignant as well as malignant pain. Devices available include mechanical constant flow pumps as well as electronic variable flow pumps with patient-controlled bolus release. The latter provide faster dose finding, individual pain control, and good acceptance by patients. New technologies such as membrane pumps and rechargeable devices are expected to be developed to clinical perfection. The available drugs for intrathecal therapy are listed according to the polyanalgesic consensus on intrathecal therapy. The integration of remote patient-controlled analgesia into electronic implantable devices, and the peptide analgesic ziconotide, have significantly improved intrathecal therapy. Complications include infections, catheter ruptures or disconnections, catheter granulomas, and technical dysfunctions. Further possibilities for optimizing intrathecal therapy include development of new drugs, drug side effects, catheter and pump technologies, and surgical techniques.Keywords: intrathecal therapy, implantable pumps, morphine pumps, intrathecal drugs, intrathecal catheters, intrathecal pain control
format article
author Boris Todoroff
Wilfried Ilias
author_facet Boris Todoroff
Wilfried Ilias
author_sort Boris Todoroff
title Optimizing pain control through the use of implantable pumps
title_short Optimizing pain control through the use of implantable pumps
title_full Optimizing pain control through the use of implantable pumps
title_fullStr Optimizing pain control through the use of implantable pumps
title_full_unstemmed Optimizing pain control through the use of implantable pumps
title_sort optimizing pain control through the use of implantable pumps
publisher Dove Medical Press
publishDate 2008
url https://doaj.org/article/16e8761409ee41a3bfb4c4c7f4f53f95
work_keys_str_mv AT boristodoroff optimizingpaincontrolthroughtheuseofimplantablepumps
AT wilfriedilias optimizingpaincontrolthroughtheuseofimplantablepumps
_version_ 1718403365739692032